| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Sara van den Berg | Q92865512 |
| P2093 | author name string | D van Baarle | |
| M J Knol | |||
| K Warmink | |||
| J A M Borghans | |||
| P2860 | cites work | Influenza-attributable deaths, Canada 1990-1999 | Q57706328 |
| Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection | Q59357739 | ||
| Role of cytomegalovirus in the T cell changes seen in elderly individuals | Q74612247 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines | Q27025076 | ||
| Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| Influenza-associated hospitalizations in the United States | Q29619463 | ||
| Cytomegalovirus infection enhances the immune response to influenza. | Q30300254 | ||
| Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. | Q30352081 | ||
| Influenza-associated intensive-care unit admissions and deaths - California, September 29, 2013-January 18, 2014. | Q30359271 | ||
| Tools to detect influenza virus | Q30428951 | ||
| Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus | Q31163002 | ||
| Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons | Q33737729 | ||
| Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging | Q34390499 | ||
| Immune senescence: relative contributions of age and cytomegalovirus infection | Q34390507 | ||
| Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study. | Q35044138 | ||
| Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine | Q35155784 | ||
| Relationship between functional ability in older people, immune system status, and intensity of response to CMV | Q35853687 | ||
| Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes | Q36180046 | ||
| Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years | Q36428456 | ||
| Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach | Q36445635 | ||
| Statistics corner: A guide to appropriate use of correlation coefficient in medical research | Q36622758 | ||
| Immunosenescence of ageing | Q36698262 | ||
| Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. | Q36760142 | ||
| Cytomegalovirus infection: a driving force in human T cell immunosenescence | Q36994757 | ||
| Immunobiology of human cytomegalovirus: from bench to bedside. | Q37050965 | ||
| Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults | Q37470923 | ||
| Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection | Q37766571 | ||
| Role of CMV in immune senescence | Q37792338 | ||
| Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial | Q38380582 | ||
| Aging, cytomegalovirus (CMV) and influenza vaccine responses | Q38640148 | ||
| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
| Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. | Q39054189 | ||
| Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. | Q39310460 | ||
| Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines | Q39320852 | ||
| Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging | Q40368519 | ||
| Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status. | Q40478812 | ||
| Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade. | Q40512629 | ||
| Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio | Q40734674 | ||
| Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage | Q41928464 | ||
| Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence | Q41929983 | ||
| Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors | Q42275032 | ||
| Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study | Q43591750 | ||
| Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence | Q44551905 | ||
| Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination | Q45878269 | ||
| Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? | Q47428977 | ||
| The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose. | Q47549093 | ||
| Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults | Q49587964 | ||
| Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. | Q51475066 | ||
| Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. | Q52011231 | ||
| Scrub typhus point-of-care testing: A systematic review and meta-analysis. | Q55261212 | ||
| Early kinetics of antibody response to inactivated influenza vaccine | Q57110877 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| cytomegaloviral disease | Q2076966 | ||
| P304 | page(s) | 305-321 | |
| P577 | publication date | 2019-04-04 | |
| P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
| P1476 | title | Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis | |
| P478 | volume | 208 |
| Q96163013 | "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection? |
| Q90136333 | Immunosenescence and human vaccine immune responses |
| Q92050198 | Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses |
| Q94602411 | Recent advances in influenza vaccines |
| Q94475184 | The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
Search more.